(1)
Budget Impact Analysis of the Use of Daclatasvir in Italy for the Treatment of Hepatitis C Virus (HCV) Genotype 3 Patients. FE 2016, 17 (1), 7-12. https://doi.org/10.7175/fe.v17i1.1225.